Pharmacoeconomic analysis of classic and alternative eradication therapy regimens for Helicobacter pylori

by A. M. Veliyev, D. N. Andreyev, E. V. Partsvania-Vinogradova
Published 2019-05-01

Irritable bowel syndrome in view of the rome IV criteria (2016)

by D. T. Dicheva, D. N. Andreev, M. P. Scheglanova, E. V. Partsvania-Vinogradova
Published 2018-04-01

State of acid-producing function of the stomach in patients with helicobacter pylori-associated gastroduodenal ulcer disease and no response to eradication therapy

by G. L. Yurenev, E. V. Partsvania-Vinogradova, D. N. Andreev, D. T. Dicheva, I. V. Maev
Published 2018-04-01

The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C

by D N Andreev, I V Maev, Yu A Kucheryavyi, D T Dicheva, E V Partsvania-vinogradova
Published 2016-04-01

DIAGNOSIS AND TREATMENT OF HELICOBACTER PYLORI INFECTION: MAIN STATEMENTS OF THE MAASTRICHT V/FLORENCE CONSENSUS REPORT (2015)

by I. V. Maev, D. N. Andreev, D. T. Dicheva, Yu. A. Kucheryavyy, A. V. Zaborovskiy, E. V. Partsvania-Vinogradova
Published 2017-04-01

Difficulties of differential diagnosis of portal hypertension: case report

by T. V. Penkina, O. E. Berezutskaya, D. T. Dicheva, E. V. Partsvania-Vinogradova, V. S. Larina, R. M. Umyarova, D. V. Borzova, E. V. Ulyankina
Published 2021-05-01